199 related articles for article (PubMed ID: 12849298)
1. Immunotherapy in autoimmune neuromuscular disorders.
Gold R; Dalakas MC; Toyka KV
Lancet Neurol; 2003 Jan; 2(1):22-32. PubMed ID: 12849298
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in neuromuscular disorders: current and future strategies.
Drachman DB
Muscle Nerve; 1996 Oct; 19(10):1239-51. PubMed ID: 8808649
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in autoimmune diseases.
Miller A; Hafler DA; Weiner HL
Curr Opin Immunol; 1991 Dec; 3(6):936-40. PubMed ID: 1793539
[TBL] [Abstract][Full Text] [Related]
4. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction.
Liyanage Y; Hoch W; Beeson D; Vincent A
Muscle Nerve; 2002 Jan; 25(1):4-16. PubMed ID: 11754179
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular diseases account for a major burden in the field of neurological diseases in the wealthy part of the world.
Léger JM
Curr Opin Neurol; 2012 Oct; 25(5):521-2. PubMed ID: 22960497
[No Abstract] [Full Text] [Related]
6. Antigen-based immunotherapy for autoimmune disease: from animal models to humans?
Tian J; Olcott A; Hanssen L; Zekzer D; Kaufman DL
Immunol Today; 1999 Apr; 20(4):190-5. PubMed ID: 10203718
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Kuhn C; Weiner HL
Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
[TBL] [Abstract][Full Text] [Related]
8. Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases.
Shakya AK; Nandakumar KS
Trends Biotechnol; 2018 Jul; 36(7):686-699. PubMed ID: 29588069
[TBL] [Abstract][Full Text] [Related]
9. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?
Tarner IH; Fathman CG
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):491-9. PubMed ID: 16951704
[TBL] [Abstract][Full Text] [Related]
10. Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.
Yu C; Xi J; Li M; An M; Liu H
Bioconjug Chem; 2018 Mar; 29(3):719-732. PubMed ID: 29165988
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases.
Miller A; Hafler DA; Weiner HL
FASEB J; 1991 Aug; 5(11):2560-6. PubMed ID: 1868980
[TBL] [Abstract][Full Text] [Related]
12. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
Wauben MH
Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
Miller SD; Turley DM; Podojil JR
Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune muscular pathologies.
Dalakas MC
Neurol Sci; 2005 May; 26 Suppl 1():S7-8. PubMed ID: 15883700
[TBL] [Abstract][Full Text] [Related]
15. Design of effective immunotherapy for human autoimmunity.
Feldmann M; Steinman L
Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
[TBL] [Abstract][Full Text] [Related]
16. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
Soueidan SA; Dalakas MC
Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
[TBL] [Abstract][Full Text] [Related]
17. Vaccines to prevent and treat autoimmune diseases.
Mor F; Cohen IR
Int Arch Allergy Immunol; 1995 Dec; 108(4):345-9. PubMed ID: 7580306
[TBL] [Abstract][Full Text] [Related]
18. Mucosal modulation of immune responses to heat shock proteins in autoimmune arthritis.
Bonnin D; Albani S
Biotherapy; 1998; 10(3):213-21. PubMed ID: 9559976
[TBL] [Abstract][Full Text] [Related]
19. Biotherapies of neuromuscular disorders.
Briand JF; Roy MO; Mourlane F; André C; Loux N; Rougeau C; Toursel T; Braun S
Rev Neurol (Paris); 2014 Dec; 170(12):799-807. PubMed ID: 25459122
[TBL] [Abstract][Full Text] [Related]
20. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.
Liblau R; Tisch R; Bercovici N; McDevitt HO
Immunol Today; 1997 Dec; 18(12):599-604. PubMed ID: 9425739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
